Directory Image
This website uses cookies to improve user experience. By using our website you consent to all cookies in accordance with our Privacy Policy.

Learn details of the Image-Based Cytometer Market Forecast and Segments, 2017-2027

Author: Ankush Nikam
by Ankush Nikam
Posted: May 11, 2017

Cell cultivation in an indispensable part for applications within medicine and scientific investigation. From simple substance test to cell therapies, cell technologies are completely based on the controlled propagation of cells. To achieve this goal non-invasive characterization of the cell population is to be established. Microscope is the oldest piece of equipment required for cell culture but with the advances in technology, these are now automated microscopes combined with computerized image analysis. But image-based cytometry is much more capable than just describing cell cultures in terms of numbers.

Image-based Cytometer Market: Drivers and Restraints

The demand for image-based cytometer is expected to propel due to technological advancements, increasing use of image-based cytometer in clinical trials, development of intuitive software and the growing utilization of image-based flow cytometers in research activities. The Jefferson Trust, awarded US$ 775,000 to universities to engage faculty and students in research. Mass Cytometry Antibody Bank was awarded US$ 35,000, q new technology which simultaneously measures 100 different cellular attributes of thousands of individual cells. The major hurdle for the researchers to access such technologies is the high cost related to buying antibodies. Through this funding, this hurdle was overcame and could act as support for future donations.

Request Report Sample@ http://www.futuremarketinsights.com/reports/sample/rep-gb-3543

Image-based Cytometer Market: Segmentation

On the basis of application the image-based cytometer market can be segment as:

  • Research

  • Clinical

  • Others

On the basis of end user the image-based cytometer market can be segment as:

  • Hospital

  • Commercial Organizations

  • Clinical Testing Labs

  • Others

Image-based Cytometer Market: Overview

High throughput screening is available in almost all the recent technologies introduced. This is because of the emerging trend towards precision medicine where each clinical trial is towards a specific cell. Thus cell analyzer are also developed such as they provide the researcher with multifunctional results of thousands of cells. With the increasing research undertakings and the potential offered for the equipment related the demand for image-based cytometer market is expected to propel. Moreover, market players are expanding their presence by developing a new technology or by growing in emerging countries.

Image-based Cytometer Market: Region-wise Outlook

In terms of geography, image-based cytometer market has been divided into five regions including North- America, Asia- Pacific, Middle-East & Africa, Latin America and Europe. North America is expected to remain the dominating region while Asia Pacific is expected to emerge as a fastest growing region. ChemoMetec A/S established its first international sales subsidiary in Australia to be closer to its customer and addressing the issues quickly.

Image-based Cytometer Market: Key Market Participants

Some of the image-based cytometer market participants are Invitrogen, ChemoMetec A/S, Nexcelom Bioscience LLC., Vala Sciences Inc., Merck KGaA, GE Healthcare, Yokogawa Electric Corporation and Thorlabs, Inc.

About the Author

Future Market Insights is the premier provider of market intelligence and consulting services, serving clients in over 150 countries. Fmi is headquartered in London, the global financial capital, and has delivery centers in the U.S. and India

Rate this Article
Leave a Comment
Author Thumbnail
I Agree:
Comment 
Pictures
Author: Ankush Nikam

Ankush Nikam

Member since: Mar 17, 2017
Published articles: 1476

Related Articles